The Pfizer Clinical Research Unit in New Haven is looking for healthy adult volunteers interested in supporting obesity and weight-management research in New Haven, CT.

Obesity is a chronic weight condition that increases the potential risk of other illnesses such as stroke and diabetes. By 2030, it is projected that over a billion people worldwide will be considered obese.

While the scientific and medical community defines obesity as a complex, multifactorial disease requiring prevention and treatment efforts, there is still stigma associated with this condition that impacts patients’ quality of life and access to care. Most people with obesity do not receive any treatment, and diet and lifestyle changes are often not effective or accessible for everyone. Research into additional medication options is therefore essential for patients’ long-term well-being.

Participating in these studies

Participating in clinical trials is always your choice. If you are interested, find out if you are eligible by reading below or contact us to talk to our staff.

We are seeking healthy adult volunteers, meaning that participants are in overall good, stable health. Each study may have unique criteria, but in general participants must meet the following requirements: 

  • Current BMI between 16 and 45
  • Willing and able to travel to our facility in New Haven, CT for study participation*
  • Willing to take a study drug

*participants may be eligible to receive a bonus for study travel, ask our staff for details

There are other requirements for participation for each study. When you are invited to join a specific clinical trial, other criteria may be assessed to determine if you can participate. The study staff will explain these criteria to you during the screening process.

 

Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus. 

Learn more

Condition

Healthy

Age

18+ years

Sex

All sexes

Referral bonus

Varies by study

This information is a summary of the eligibility criteria across the studies in this program. Each study will have its own unique requirements for who may participate (eligibility criteria). To learn more about the requirements for a study that is actively recruiting, visit the study’s webpage below. Only the research study staff can determine if you qualify to enroll in the study.

Current Studies

Recruiting
Study Drug for Obesity: SC Injection
The Pfizer Clinical Research Unit is conducting a clinical trial with healthy volunteers to look at the effects of a study drug for obesity given as a single injection beneath the skin (subcutaneous [SC] injection).

Recruiting healthy volunteers with BMI >27; Sex: All; Age: 18+; Compensation: Up to $6,100 upon completion of the study

View study C6491016

Healthy Volunteers in Obesity Clinical Trials

Obesity is a complex disease influenced by a person’s genes, hormones, and other conditions, and can lead to other serious health complications. Many people incorrectly believe that the solution to obesity and related conditions is to diet and exercise, but these are sometimes not accessible or effective for all patients. We know alternatives are needed, including medication options, to support patients’ long-term health and well-being, and more research is necessary to provide the best care possible.

Phase 1 clinical trials often involve people without the condition being studied, called healthy participants. Including healthy participants helps us understand how a study drug or study vaccine affects the body, determine proper dosing, and collect information about possible side effects. This is one way to learn more about a potential treatment before giving it to patients with complex medical histories.

In some obesity clinical trials, healthy participants may also need to meet certain BMI criteria. Because things like weight and metabolism can impact how medication works, it’s important to include participants that resemble the patient population. This improves the accuracy and reliability of the data and ensures that future patients receive medications founded on high-quality research.

A researcher wearing a lab coat and other PPE checks a sample in front of a computer and other lab equipment during a clinical trial at the PCRU.
A researcher wearing a lab coat and other PPE checks a sample in front of a computer and other lab equipment during a clinical trial at the PCRU.

About the Pfizer Clinical Research Unit in New Haven, CT

Many of Pfizer’s phase 1 clinical trials take place at the Pfizer Clinical Research Unit (PCRU) in New Haven, Connecticut.

Located in the heart of New Haven, our clinical research unit is a modern facility that provides study-related clinical care and monitoring of the participants in these clinical trials. The New Haven PCRU has 57 inpatient beds as well as outpatient facilities. Many of the studies include overnight stays. Within the unit, you’ll have access to internet, a large relaxation and reading area, and a multimedia room for entertainment. There is also a terrace available for fresh air and off-street parking for participants.

For more information about the PCRU – including FAQs, pictures, promotions, and participant testimonials – view the PCRU Homepage.

Interested in participating?

Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. 

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

For Japanese language assistance only, please call 1-833-711-9984. 

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.

All fields marked with * are required.

(We will do our best to contact you during this window when possible)

Cancel